Using chest ultrasound to differentiate between lung congestion and pneumonia in critically ill adults
The Role of Chest Ultrasound in Differentiating Lung Congestion and Pneumonia in Adult Critically-ill Patients and Its Prognostic Impact
Assiut University · NCT05636631
This study tests if chest ultrasound can help doctors tell the difference between pneumonia and lung congestion in critically ill adults.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 60 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assiut University (other) |
| Drugs / interventions | radiation |
| Locations | 1 site (Assiut, Asyut) |
| Trial ID | NCT05636631 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of chest ultrasound as a diagnostic tool for differentiating between pneumonia and lung congestion in critically ill patients. It focuses on the use of lung ultrasound (LUS) in emergency and critical care settings, highlighting its rapid, low-cost nature and the absence of harmful radiation. The study will assess the ability of LUS to identify specific sonographic signs that indicate various lung pathologies, thereby guiding patient management and follow-up. The research will involve adult patients admitted to critical care units who exhibit symptoms suggestive of pneumonia or acute congestive heart failure.
Who should consider this trial
Good fit: Ideal candidates for this study are adults over 18 years old, of any gender, who exhibit symptoms suggestive of pneumonia or acute congestive heart failure and are admitted to a critical care unit.
Not a fit: Patients with renal-induced lung congestion may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance diagnostic accuracy and improve patient outcomes in critically ill patients with respiratory conditions.
How similar studies have performed: Other studies have shown promising results using lung ultrasound for similar diagnostic purposes, indicating that this approach is both relevant and potentially effective.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult (above 18 years old) * Both genders * Patient with symptoms suggestive of pneumonia * Patient with symptoms suggestive of acute congestive heart failure * admitted to Critical care unit Exclusion Criteria: * Patients with Renal induced lung congestion
Where this trial is running
Assiut, Asyut
- Nardin Aymn — Assiut, Asyut, Egypt (RECRUITING)
Study contacts
- Study coordinator: Nardin Aymn, resident
- Email: Nardeen.14223960@med.aun.edu.eg
- Phone: 01285151220
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Pneumonia, Pulmonary Edema